Abstract:Chunkun Yang, 1, &ast Qinwei Zhu, 2, &ast Yanbo Chen, 3, &ast Kui Ji, 2 Shuanghong Li, 2 Qian Wu, 1 Qingquan Pan, 2 Jun Li 1 1 Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; 2 Department of Emergency, Weifang Hospital of Traditional Chinese Medicine, Weifang, Shandong, People's Republic of China; 3 Department of Arrhythmia, Weifang People's Hospital, Weifang, Shandong, People's Republic of China &astThese authors contributed equally to this workThese authors contributed equally to this work Correspondence: Jun Li, Email Cardiovascular diseases (CVDs) are the most common cause of death worldwide and has been the focus of research in the medical community. Curcumin is a polyphenolic compound extracted from the root of turmeric. Curcumin has been shown to have a variety of pharmacological properties over the past decades. Curcumin can significantly protect cardiomyocyte injury after ischemia and hypoxia, inhibit myocardial hypertrophy and fibrosis, improve ventricular remodeling, reduce drug-induced myocardial injury, improve diabetic cardiomyopathy(DCM), alleviate vascular endothelial dysfunction, inhibit foam cell formation, and reduce vascular smooth muscle cells(VSMCs) proliferation. Clinical studies have shown that curcumin has a protective effect on blood vessels. Toxicological studies have shown that curcumin is safe. But high doses of curcumin also have some side effects, such as liver damage and defects in embryonic heart development. This article reviews the mechanism of curcumin intervention on CVDs in recent years, in order to provide reference for the development of new drugs in the future. Keywords: curcumin, intima, endothelial cells, vascular smooth muscle cell, cardiovascular diseases, inflammation, apoptosis CVDs, disorders of the heart and blood vessels, are a major health problem worldwide, causing the largest number of deaths, and its incidence is still rising. It is estimated that nearly 20 million people worldwide died from CVDs in 2016, accounting for one-third of all deaths. It is predicted that by 2030, 40.5% of Americans will have CVDs, which will result in about 276 billion in indirect costs. 1 However, many people fail to recognize the risk of CVDs. Individuals at risk for CVDs may present high blood pressure, weight issues, and altered glucose or lipid levels. Great progress has been made in the research of the pathogenesis mechanism of CVDs, but the morbidity and mortality of CVDs are still very high. There is an urgent need for drugs that are more effective and have minimal side effects to prevent and treat these diseases. Compared to traditional drugs, natural drugs have many advantages, such as fewer side effects, low long-term toxicity, and variable bioavailability. 2 Curcuma originated in India and has a history of 6000 years. About 700 AD, Curcuma was introduced into China and was first recorded in the New Materia Medica . In 1815, curcumin was isolated in an impalured form by Milobedeska and Lampe. It was not until 1910 that the chemical structure of curcumin was determined and could be synthesized chemically. Curcumin is a bioactive component of the curry spice, and its pleiotropic effects in CVDs suggest that it is a promising drug candidate. Specifically, curcumin can significantly alleviate vascular endothelial dysfunction, inhibit foam cell formation, reduce VSMCs proliferation, protect cardiomyocyte injury after ischemia and hypoxia, inhibit myocardial hypertrophy and fibrosis, improve ventricular remodeling, reduce drug-induced myocardial injury, and improve DCM. 3,4 The current research on curcumin is scattered. In order to further clarify the mechanism of curcumin in CVDs, this study systematically summarized the research reports on curcumin in recent years (Figure 1). Figure 1 ( A ) Curcuma . ( B ) Curcuma Decoction pieces. ( C ) New Materia Medica and Picture of Curcuma . ( D ) Chemical Structure of Curcumin. ( E ) Blood Vessels and Heart. This review is based on the guidelines and recommendations of the Preferred Reporting Project for Systematic Review and Meta-Analysis (PRISMA). All relevant articles published in PubMed between January 2010 and August 2023 were included in this review. We used the keywords "curcumin", "atherosclerosis", "vascular smooth muscle cells", "vascular endothelium", "Vascular endothelial cell", "vascular endothelium", "vascular endothelium", "plaque", "adhesion", "li -Abstract Truncated-

Research progress on curcuma zedoary extracts inhibiting vascular smooth muscle cell proliferation in pathological process of in-stent restenosis

Inhibitory effects of emodin on the proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II.

Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MbetaCD.

Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MβCD

Research Progress of the Anti-Proliferation Effect of Emodin on VSMCs

Euonymine inhibits in-stent restenosis through enhancing contractile phenotype of vascular smooth muscle cells via modulating the PTEN/AKT/mTOR signaling pathway

The research progress of hirudo on the related cells in the progression of atherosclerosis

Anti-angiogenesis effect of essential oil from Curcuma zedoaria in vitro and in vivo

Curcumin Inhibits Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation.

Tanshinone IIA inhibits VSMC inflammation and proliferation in vivo and in vitro by downregulating miR-712-5p expression

Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?

[Influence of Curcumin--loaded Poly (Lactide-Co-glycolide) Films on the Proliferation of Vascular Smooth Muscle Cells].

Curcumin Regulates VSMC Phenotype Transition via Modulation of Notch and Wnt Signaling Pathways

The effects of BuYang HuanWu Decoction and its effective components on proliferation-related factors and ERK1/2 signal transduction pathway in cultured vascular smooth muscle cells

Anti-proliferative and Anti-Migratory Effects of Scutellaria Strigillosa Hemsley Extracts Against Vascular Smooth Muscle Cells.

[Research progress in coatings with active compounds and extracts of traditional Chinese medicines for coronary intervention devices]

Curcumin Inhibits Angiotensin II-induced Inflammation and Proliferation of Rat Vascular Smooth Muscle Cells by Elevating PPAR-γ Activity and Reducing Oxidative Stress.

GW24-e1159 Curcumin Inhibits LPS-induced Inflammation in Rat Vascular Smooth Muscle Cells in Vitro Via ROS-relative TLR4-MAPK/NF-κB Pathways

Curcumin Inhibits LPS-induced Inflammation in Rat Vascular Smooth Muscle Cells in Vitro Via ROS-relative TLR4-MAPK/NF-κB Pathways.

Review of the Protective Mechanism of Curcumin on Cardiovascular Disease

Curcumin Attenuates Migration of Vascular Smooth Muscle Cells Via Inhibiting NFκB-mediated NLRP3 Expression in Spontaneously Hypertensive Rats.